Found: 18
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- 2018
- Publication type:
- Cover Art
The role of interleukin‐4 in rheumatic diseases.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 747, doi. 10.1111/1440-1681.12946
- By:
- Publication type:
- Article
Role of melatonin in blood pressure regulation: An adjunct anti‐hypertensive agent.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 755, doi. 10.1111/1440-1681.12942
- By:
- Publication type:
- Article
Differential cardiac sympatho‐inhibitory responses produced by the agonists B‐HT 933, quinpirole and immepip in normoglycaemic and diabetic pithed rats.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 767, doi. 10.1111/1440-1681.12949
- By:
- Publication type:
- Article
miR‐376b‐3p attenuates mitochondrial fission and cardiac hypertrophy by targeting mitochondrial fission factor.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 779, doi. 10.1111/1440-1681.12938
- By:
- Publication type:
- Article
Gossypol stimulates opening of a Ca<sup>2+</sup>‐ and Na<sup>+</sup>‐permeable but Ni<sup>2+</sup>‐ and Co<sup>2+</sup>‐impermeable pore in bEND.3 endothelial cells.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 788, doi. 10.1111/1440-1681.12929
- By:
- Publication type:
- Article
Activation of voltage‐gated sodium current and inhibition of erg‐mediated potassium current caused by telmisartan, an antagonist of angiotensin II type‐1 receptor, in HL‐1 atrial cardiomyocytes.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 797, doi. 10.1111/1440-1681.12943
- By:
- Publication type:
- Article
The glucagon‐like peptide‐1 receptor agonist Exendin‐4, ameliorates contrast‐induced nephropathy through suppression of oxidative stress, vascular dysfunction and apoptosis independent of glycaemia.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 808, doi. 10.1111/1440-1681.12944
- By:
- Publication type:
- Article
Down‐regulation of microRNA‐375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non‐alcoholic fatty liver disease.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 819, doi. 10.1111/1440-1681.12940
- By:
- Publication type:
- Article
Spermidine prevents high glucose‐induced senescence in HT‐22 cells by upregulation of CB1 receptor.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 832, doi. 10.1111/1440-1681.12955
- By:
- Publication type:
- Article
Long non‐coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 841, doi. 10.1111/1440-1681.12932
- By:
- Publication type:
- Article
Bone marrow ‐ mesenchymal stem cells impact on the U937 cells in the presence of staphylococcal enterotoxin B (SEB).
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 849, doi. 10.1111/1440-1681.12945
- By:
- Publication type:
- Article
Rapamycin protects against early brain injury independent of cerebral blood flow changes in a mouse model of subarachnoid haemorrhage.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 859, doi. 10.1111/1440-1681.12950
- By:
- Publication type:
- Article
Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor κ‐B ligand‐stimulated signalling pathways.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 863, doi. 10.1111/1440-1681.12941
- By:
- Publication type:
- Article
Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8‐year‐follow‐up study.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 866, doi. 10.1111/1440-1681.12928
- By:
- Publication type:
- Article
Hyperuricaemia and type 2 diabetes mellitus.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 870, doi. 10.1111/1440-1681.12937
- By:
- Publication type:
- Article
Placental adaptations to micronutrient dysregulation in the programming of chronic disease.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 871, doi. 10.1111/1440-1681.12954
- By:
- Publication type:
- Article
Retracted: ‘Anti‐fibrotic actions of Ghrelin by inhibition of the NADPH oxidase–ROS signaling pathway’ by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 8, p. 885, doi. 10.1111/1440-1681.12948
- Publication type:
- Article